Paul is new CEO at EvaluatePharma

Share this article:

EvaluatePharma named Debbie Paul to the position of CEO Americas, EvaluatePharma USA, effective immediately.

In the new post, Paul is leading the data analysis and forecasting firm's North American operations and its strategic expansion into Canada and Latin America. Jonathan de Pass remains as chief executive of the UK-based parent company, EvaluatePhar­ma Ltd., which he founded.

Paul has been with the firm since 2004, most recently serving as SVP, North America, and has 25 years of healthcare and life science industry experience, ranging from being a critical-care nurse manager to directing market research for Sandoz.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters